Market Cap (In JPY)
138.22 Billion
Revenue (In JPY)
227.93 Billion
Net Income (In JPY)
16.17 Billion
Avg. Volume
92.99 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2310.0-3240.0
- PE
- -
- EPS
- -
- Beta Value
- -0.062
- ISIN
- JP3623150004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Itsuro Yoshida
- Employee Count
- -
- Website
- https://www.towayakuhin.co.jp
- Ipo Date
- 2004-04-05
- Details
- Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
More Stocks
-
IB
-
BTGGFBitcoin Group SE
BTGGF
-
ABBOTINDIAAbbott India Limited
ABBOTINDIA
-
002808
-
LINKPHLink Pharma Chem Limited
LINKPH
-
DICINDDIC India Limited
DICIND
-
CNTRFCENTR Brands Corp.
CNTRF
-
SRS